scispace - formally typeset
D

Daniel Fábio Kawano

Researcher at State University of Campinas

Publications -  48
Citations -  1506

Daniel Fábio Kawano is an academic researcher from State University of Campinas. The author has contributed to research in topics: Pharmacophore & Medicine. The author has an hindex of 11, co-authored 45 publications receiving 1204 citations. Previous affiliations of Daniel Fábio Kawano include University of São Paulo & Universidade Federal do Rio Grande do Sul.

Papers
More filters
Journal ArticleDOI

Carrageenans: biological properties, chemical modifications and structural analysis - a review.

TL;DR: This review describes important aspects of carrageenans related to their industrial/therapeutic applications, physicochemical properties and structural analysis and indicates that these polysaccharides may offer some protection against HIV infection.
Journal ArticleDOI

Acidentes com os medicamentos: como minimizá-los?

TL;DR: In this article, the adoption of electronic systems in medicine prescription as a support to the clinical decision can significantly reduce the occurrence of adverse events related to medicines, improving the quality and efficiency of the pharmacological treatment.
Journal ArticleDOI

Imidazoles and benzimidazoles as tubulin-modulators for anti-cancer therapy.

TL;DR: The understanding of the mechanisms involved in the imidazole/benzimidazoles modulation of microtubule dynamics is very important to develop new strategies to overcome the resistance to anti-cancer drugs and to discover new biomarkers and targets for cancer chemotherapy.
Journal ArticleDOI

New Insights into the Chemistry and Antioxidant Activity of Coumarins

TL;DR: This analysis includes the synthesis of some complex antioxidant coumarins, strategies for structural modification to improve their antioxidant activities, qualitative/ quantitative structure-antioxidant relationships studies and the main in vitro assays used to evaluate their antioxidant properties.
Journal ArticleDOI

Psoralen and bergapten: in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo.

TL;DR: This work is believed to add to the knowledge of which molecular substructures are relevant to the process of metabolism and toxicity induction, thus guiding the search and development of more effective and less toxic drugs to treat vitiligo.